A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Cellerant Therapeutics
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)